Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA

@article{Seywright2016AnalysisAC,
  title={Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA},
  author={A. Seywright and H. Torrance and F. M. Wylie and D. McKeown and D. Lowe and R. Stevenson},
  journal={Clinical Toxicology},
  year={2016},
  volume={54},
  pages={632 - 637}
}
  • A. Seywright, H. Torrance, +3 authors R. Stevenson
  • Published 2016
  • Medicine
  • Clinical Toxicology
  • Abstract Context: MDMB-CHMICA is a synthetic cannabinoid receptor agonist which has caused concern due to its presence in cases of adverse reaction and death. Method: 43 cases of suspected synthetic cannabinoid ingestion were identified from patients presenting at an Emergency Department and from post-mortem casework. These were subjected to liquid-liquid extraction using tertiary-butyl methyl ether and quantitatively analysed by Electrospray Ionisation Liquid Chromatography–tandem Mass… CONTINUE READING
    Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist
    • 6
    Cannabinoids: from pot to lab
    • 15
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 24 REFERENCES
    Toxicological findings of synthetic cannabinoids in recreational users.
    • 93
    • PDF
    Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series
    • 40
    Synthetic cannabinoids
    • 85
    • PDF
    SODAS: Surveillance of Drugs of Abuse Study
    • 5
    Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
    • 111
    • PDF
    Synthetic Cannabinoids
    • 41